Brief: NextCell Pharma Board Intends To Decide On Fully Guaranteed Rights Issue Of Up To Around SEK 150 Mln
Nov 20 (Reuters) - NextCell Pharma AB NXTCL.ST :
* BOARD INTENDS TO DECIDE ON A FULLY GUARANTEED RIGHTS ISSUE
OF UP
TO AROUND SEK 150 MILLION
* SUBSCRIPTION PRICE SEK 15.0 PER SHARE
* SUBSCRIPTION PERIOD EXPECTED TO RUN FROM DEC 7 - DEC 21,
2020
Source text for Eikon: ID:nWkr6m1RNL
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln